1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,600 | 8,900 | 21:09 | |
| 8,600 | 8,900 | 20:24 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.06. | CARLSMED, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet | 2 | Zacks | ||
| 06.05. | Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar | 1 | Seeking Alpha | ||
| 05.05. | Carlsmed, Inc. GAAP EPS of -$0.32, revenue of $16.1M | 3 | Seeking Alpha | ||
| 05.05. | Carlsmed Q1 2026 Earnings Call: Complete Transcript | 1 | Benzinga.com | ||
| CARLSMED Aktie jetzt für 0€ handeln | |||||
| 05.05. | Carlsmed Reports First Quarter 2026 Financial Results | 124 | GlobeNewswire (Europe) | First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 05.05. | CARLSMED, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.04. | Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 | 1 | GlobeNewswire (USA) | ||
| 26.02. | Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M | 1 | Seeking Alpha | ||
| 26.02. | Carlsmed targets $70M-$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook | 3 | Seeking Alpha | ||
| 25.02. | CARLSMED, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 25.02. | Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results | 964 | GlobeNewswire (Europe) | Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed"... ► Artikel lesen | |
| 25.02. | CARLSMED, INC. - 8-K, Current Report | - | SEC Filings | ||
| 19.02. | Carlsmed Unveils Custom Cervical Plating Tech | 1 | Benzinga.com | ||
| 11.02. | Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 | 2 | GlobeNewswire (USA) | ||
| 10.02. | Carlsmed Announces First aprevo Bi-lateral Posterior Lumbar Interbody Fusion Procedure | 644 | GlobeNewswire (Europe) | CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), today announced the successful completion of the first posterior lumbar spine surgery... ► Artikel lesen | |
| 12.01. | Carlsmed: Umsatz steigt im vierten Quartal 2025 um 61 % | 1 | Investing.com Deutsch | ||
| 12.01. | Carlsmed reports 61% revenue growth in Q4 2025 | 1 | Investing.com | ||
| 12.01. | Carlsmed Reports Q4, FY 2025 revenue above estimate | 3 | Seeking Alpha | ||
| 12.01. | Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 | 597 | GlobeNewswire (Europe) | Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024 CARLSBAD, Calif., Jan. 12, 2026 (GLOBE... ► Artikel lesen |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,610 | +0,76 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Die Bedenken im Deutschen Bundesrat bezüglich staatlicher Kürzungen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,700 | -1,36 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,230 | -0,58 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,670 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| PROGYNY | 26,080 | 0,00 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| BRIGHTSPRING HEALTH SERVICES | 66,21 | -0,06 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| OTTOBOCK | 50,30 | 0,00 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock verkauft Rollstuhlgeschäft "Human Mobility" | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Verkauf/Strategische Unternehmensentscheidung
Ottobock verkauft Rollstuhlgeschäft "Human Mobility"
19.06.2026 / 11:30... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,720 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,855 | -0,02 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| AGAPE ATP | 3,880 | 0,00 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 8,950 | -0,33 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| BILLIONTOONE | 104,29 | -0,82 % | BillionToOne, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 24,940 | +0,40 % | Carl Zeiss Meditec AG: ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing | ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining... ► Artikel lesen | |
| CLEARPOINT NEURO | 17,780 | +0,06 % | ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? | ||
| GERRESHEIMER | 25,600 | -1,31 % | Gerresheimer-Aktie: Wissen die Insider mehr? | Die Gerresheimer-Aktie hat sich in den vergangenen Monaten eindrucksvoll erholt. Nach dem Absturz auf rund 16 € Ende Februar notiert sie inzwischen wieder deutlich höher. Am Montag startet sie aktuell... ► Artikel lesen |
CARLSMED INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,100 (+1,18 %) liegt der Kurs bei 8,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CARLSMED INC finden Sie auf Wallstreet Online.